Related Experiment Video
Updated: Jul 24, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Regulation, targets and functions of CSK
Shudong Zhu1, Hui Wang1, Kamakshi Ranjan2
1School of Medicine, Nantong University, Nantong, China.
Abstract:
The Src family kinases (SFK) plays an important role in multiple signal transduction pathways. Aberrant activation of SFKs leads to diseases such as cancer, blood disorders, and bone pathologies. By phosphorylating and inactivating SFKs, the C-terminal Src kinase (CSK) serves as the key negative regulator of SFKs. Similar to Src, CSK is composed of SH3, SH2, and a catalytic kinase domain. However, while the Src kinase domain is intrinsically active, the CSK kinase domain is intrinsically inactive. Multiple lines of evidence indicate that CSK is involved in various physiological processes including DNA repair, permeability of intestinal epithelial cells (IECs), synaptic activity, astrocyte-to-neuron communication, erythropoiesis, platelet homeostasis, mast cell activation, immune and inflammation responses. As a result, dysregulation of CSK may lead to many diseases with different underlying molecular mechanisms. Furthermore, recent findings suggest that in addition to the well-established CSK-SFK axis, novel CSK-related targets and modes of CSK regulation also exist. This review focuses on the recent progress in this field for an up-to-date understanding of CSK.
Insights
C-terminal Src kinase (CSK) negatively regulates Src family kinases (SFKs), impacting numerous cellular processes. Dysregulation of CSK is linked to various diseases, with emerging research revealing novel targets and regulatory mechanisms.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Src family kinases (SFKs) are crucial in signal transduction, and their aberrant activation is implicated in diseases like cancer.
- C-terminal Src kinase (CSK) acts as a key negative regulator of SFKs by phosphorylating them.
- CSK, like Src, possesses SH3, SH2, and catalytic kinase domains, but its kinase domain is intrinsically inactive.
Purpose of the Study:
- To review recent advancements in understanding C-terminal Src kinase (CSK).
- To highlight the diverse physiological roles of CSK beyond its established interaction with SFKs.
- To explore novel CSK targets and regulatory mechanisms.
Main Methods:
- Literature review of recent scientific findings on CSK.
- Analysis of studies investigating CSK's involvement in various physiological processes.
- Examination of research on novel CSK-related targets and regulation.
Main Results:
- CSK plays a critical role in DNA repair, intestinal epithelial cell permeability, synaptic activity, and immune responses.
- Dysregulation of CSK is associated with diverse pathologies, including cancer and blood disorders.
- Emerging evidence points to new CSK targets and regulatory pathways beyond the canonical CSK-SFK axis.
Conclusions:
- CSK is a vital regulator with broad physiological functions, and its dysregulation contributes to multiple diseases.
- Further research into novel CSK targets and regulatory mechanisms is essential for a comprehensive understanding.
- CSK represents a promising area for therapeutic intervention in various disease contexts.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Regulation of Nuclear Protein Sorting
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Positive Regulator Molecules
The Cell Cycle Control System

